Results 91 to 100 of about 1,541,059 (150)

Letter: Defining the Incremental Predictive Value of HBsAg in Hepatocellular Carcinoma Risk Prediction, Authors' Reply. [PDF]

Aliment Pharmacol Ther
Guo YF, Guo C, Ji D, Niu XX.
europepmc   +1 more source

Validation of Texas Hepatocellular Carcinoma Consortium Risk Index in the Hepatocellular Carcinoma Early Detection Strategy Study. [PDF]

Clin Gastroenterol Hepatol
Kanwal F, Lopez C, Ning J, Luster M, Reddy KR, Parikh ND, Singal AG, Marrero JA, Chhatwal J, Feng Z, Page-Lester S, Koay EJ, El-Serag HB.   +12 more
europepmc   +1 more source

Anatomically-guided Masked Autoencoder with Domain-Adaptive Prompting (AMAP) for multimodal cerebral aneurysm detection and segmentation. [PDF]

NPJ Digit Med
Huang M, Liu T, Zhang J, Su X, Chen H, Li M, Guo J, Zu K, Chen X, Su Y, Cong H, Yan L, Yan T, Deng Y.   +13 more
europepmc   +1 more source

Hepatocellular Carcinoma Risk Stratification for Cirrhosis Patients: Integrating Radiomics and Deep Learning Computed Tomography Signatures of the Liver and Spleen into a Clinical Model. [PDF]

J Clin Transl Hepatol
Fan R, Shi YR, Chen L, Wang CX, Qian YS, Gao YH, Wang CY, Fan XT, Liu XL, Bai HL, Zheng D, Jiang GQ, Yu YL, Liang XE, Chen JJ, Xie WF, Du LT, Yan HD, Gao YJ, Wen H, Liu JF, Liang MF, Kong F, Sun J, Ju SH, Wang HY, Hou JL.   +26 more
europepmc   +1 more source

An artificial intelligence model for prediction of hepatocellular carcinoma risk in patients with chronic hepatitis C. [PDF]

Sci Rep
Lee YR, Lee H, Tak WY, Kweon YO, Son W, Kim K, Park SY.   +6 more
europepmc   +1 more source

BALAD-2 Emerges as the Most Accurate Prognostic Model in Hepatocellular Carcinoma: Results from a Biobank-Based Cohort Study. [PDF]

Cancers (Basel)
Demirtas CO, Eren F, Yilmaz Karadag D, Kaldirim Armutcuoglu Y, Tolu T, Huseyinov J, Ciftci U, Yilmaz T, Akin S, Dilber F, Ozdogan OC.   +10 more
europepmc   +1 more source

The Alpha-1 Pi*MZ Genotype Is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients With ACLD. [PDF]

Aliment Pharmacol Ther
Balcar L, Semmler G, Scheiner B, Paternostro R, Simbrunner B, Haunold TJ, Jachs M, Hartl L, Hofer BS, Dominik N, Schwarz M, Kramer G, Sebesta C, Thöne P, Pinter M, Trauner M, Reiberger T, Stättermayer AF, Mandorfer M.   +18 more
europepmc   +1 more source

Metabolic dysfunction-associated steatotic liver disease affects the development of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients. [PDF]

J Gastroenterol
Yamasaki S, Nakahara T, Tsuge M, Yamaoka K, Fujii Y, Uchikawa S, Fujino H, Ono A, Murakami E, Kawaoka T, Miki D, Oka S.   +11 more
europepmc   +1 more source

Serial Liver Stiffness Measurement and Serum Biomarkers Are Not Strong Predictors of the Regression of Fibrosis among Chronic Hepatitis B Patients Receiving Antiviral Therapy Based on Triple Liver Biopsies. [PDF]

Gut Liver
Zhang J, Chen S, Zhou J, Wang B, Wu X, Xu X, Zhao X, Kong Y, Ou X, Sun Y, You H.   +10 more
europepmc   +1 more source

Prediction of Hepatocellular Carcinoma After Direct-Acting Antiviral Therapy Using Agile 3+ and End-of-Treatment Alpha-Fetoprotein Levels in Patients With Hepatitis C. [PDF]

JGH Open
Kuwano A, Yada M, Tanaka K, Hamomoto T, Kurosaka K, Suzuki H, Motomura K.   +6 more
europepmc   +1 more source